Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China flag China · Delayed Price · Currency is CNY
48.43
-1.75 (-3.49%)
May 14, 2026, 3:04 PM CST

SHE:300832 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,485997.44919.531,048483.43617.58
Short-Term Investments
-1,076-275.79110.09-
Trading Asset Securities
938.541,2671,7232,0802,8142,806
Cash & Short-Term Investments
2,4233,3402,6433,4043,4073,424
Cash Growth
-2.22%26.36%-22.36%-0.09%-0.49%1.46%
Accounts Receivable
1,0111,001957.49631.78479.97276.1
Other Receivables
10.07239.52147.9880.6642.8312.69
Receivables
1,0211,2401,105712.44522.79288.79
Inventory
1,0811,0401,198916.79839.33645.38
Prepaid Expenses
6.9911.6723.727.4432.29104.75
Other Current Assets
1,45662.1385.7523.0920.834.16
Total Current Assets
5,9885,6945,0565,0644,8224,497
Property, Plant & Equipment
1,7521,7631,6941,4421,3251,134
Long-Term Investments
1,2561,5311,974924.95357.62136.9
Other Intangible Assets
233.91237.39245.06169.46172.4894.56
Long-Term Accounts Receivable
-392.46310.8189.1793.8528.1
Long-Term Deferred Tax Assets
89.5287.3563.9837.9422.912.14
Long-Term Deferred Charges
119.19125.73150.83156.6969.0874.97
Other Long-Term Assets
777.68109.79124.8238.22150.77157.39
Total Assets
10,2169,9419,6198,2227,0156,136
Accounts Payable
176.57152.11456.62126.99176.68171.35
Accrued Expenses
76.19222.03200.59187.77149.03124.27
Current Portion of Leases
2.021.821.341.691.321.35
Current Income Taxes Payable
144.3198.3120.14120.3576.1959.92
Current Unearned Revenue
79.0987.7380.1391.48108.9477.08
Other Current Liabilities
89.9471.8949.9163.271.7873.96
Total Current Liabilities
568.12633.89908.74591.48583.94507.94
Long-Term Leases
1.71.862.763.490.890.88
Long-Term Unearned Revenue
44.9446.4347.2633.065.816.58
Long-Term Deferred Tax Liabilities
108.01106.9778.5150.0624.418.11
Other Long-Term Liabilities
6.756.765.58---
Total Liabilities
729.52795.911,043678.09615.06523.51
Common Stock
785.72785.72785.72785.72786.13786.66
Additional Paid-In Capital
1,3321,3321,3321,3321,3481,450
Retained Earnings
7,4587,0166,4175,3744,2673,411
Treasury Stock
-100----16.29-37.51
Comprehensive Income & Other
1111.1441.7252.713.991.64
Shareholders' Equity
9,4879,1458,5777,5446,3995,612
Total Liabilities & Equity
10,2169,9419,6198,2227,0156,136
Total Debt
3.723.684.15.182.222.24
Net Cash (Debt)
2,4203,3362,6393,3993,4053,422
Net Cash Growth
-2.21%26.42%-22.36%-0.17%-0.49%1.40%
Net Cash Per Share
3.084.253.364.334.334.35
Filing Date Shares Outstanding
785.76785.72785.72785.72786.13786.66
Total Common Shares Outstanding
785.76785.72785.72785.72786.13786.66
Working Capital
5,4205,0604,1474,4734,2383,989
Book Value Per Share
12.0711.6410.929.608.147.13
Tangible Book Value
9,2538,9078,3327,3756,2275,517
Tangible Book Value Per Share
11.7811.3410.609.397.927.01
Buildings
-1,0611,0611,061541.55516.8
Machinery
-887.94811.8659.08512.48427.32
Construction In Progress
-549.45414.56169.32605.7442.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.